Core Insights - Keysight (KEYS) is expected to report quarterly earnings of $1.99 per share, marking a 9.3% increase year-over-year, with revenues projected at $1.54 billion, reflecting an 18.6% year-over-year growth [1] Revenue Projections - Analysts predict 'Revenue- Communications Solutions Group' will reach $1.06 billion, indicating a year-over-year change of +19.8% [4] - 'Revenue- Commercial Communications' is estimated to be $712.79 million, suggesting a +24.6% year-over-year increase [4] - 'Revenue- Aerospace, Defense & Government' is expected to be $344.85 million, with a +10.9% year-over-year change [4] - 'Revenue- Electronic Industrial Solutions Group' is forecasted at $482.39 million, reflecting a +16.2% change from the prior-year quarter [5] Income from Operations - 'Income from operations- Electronic Industrial Solutions Group' is projected to reach $128.55 million, compared to $114.00 million reported in the same quarter last year [5] - 'Income from operations- Communications Solutions Group' is expected to be $267.07 million, up from $240.00 million reported in the same quarter last year [6] Stock Performance - Keysight shares have increased by +10.6% over the past month, contrasting with a -1.3% change in the Zacks S&P 500 composite [6] - Keysight holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the overall market in the near future [6]

Core Viewpoint - Analysts project Ovintiv (OVV) will report quarterly earnings of $0.98 per share, reflecting a 27.4% decline year over year, with revenues expected to reach $1.95 billion, down 11% from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 2.7% in the past 30 days, indicating a reassessment of initial estimates by covering analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Estimates - The consensus estimate for 'Revenues - Canadian Operations' is $706.65 million, showing a year-over-year increase of 10.9% [5]. - 'Revenues - USA Operations' are projected to be $1.20 billion, indicating a significant decline of 57.4% from the prior-year quarter [5]. Production Volumes - 'Production Volumes - Oil & Plant Condensate - Total' is expected to reach 208.02 thousand barrels of oil per day, slightly down from 209.70 thousand barrels per day a year ago [5]. - 'Production Volumes - NGLs - Other - Total' is projected at 95.53 thousand barrels per day, up from 90.10 thousand barrels per day in the previous year [6]. - Total production volumes are expected to be 621.13 thousand barrels of oil equivalent per day, compared to 579.90 thousand barrels per day in the same quarter last year [6]. - 'Production Volumes - Oil - Total' is estimated at 139.91 thousand barrels per day, down from 167.10 thousand barrels per day a year ago [7]. - 'Production Volumes - Oil & NGLs - Total' is projected at 303.71 thousand barrels per day, slightly up from 299.80 thousand barrels per day in the previous year [9]. - 'Production Volumes - Total - Canadian Operations' is expected to be 306.89 thousand barrels of oil equivalent per day, compared to 235.20 thousand barrels per day a year ago [10]. - 'Production Volumes - Total - USA Operations' is estimated at 314.16 thousand barrels of oil equivalent per day, down from 344.70 thousand barrels per day in the previous year [11]. - 'Production Volumes - Oil & NGLs - Canadian Operations' is projected to reach 77.47 thousand barrels per day, up from 46.50 thousand barrels per day a year ago [12]. Stock Performance - Ovintiv shares have returned +16.5% over the past month, contrasting with the Zacks S&P 500 composite's -1.3% change, although the company holds a Zacks Rank 4 (Sell), indicating expected underperformance relative to the overall market [12].

Core Viewpoint - Wall Street analysts anticipate Yeti (YETI) to report quarterly earnings of $0.88 per share, reflecting a year-over-year decline of 12%, while revenues are expected to reach $583.16 million, indicating a 5% increase from the previous year [1] Group 1: Earnings and Revenue Estimates - Analysts project Yeti's earnings per share (EPS) to be $0.88, which shows no revision in the consensus estimate over the past 30 days [1] - Revenue expectations stand at $583.16 million, marking a 5% increase compared to the same quarter last year [1] Group 2: Sales by Channel and Category - 'Net Sales by Channel- Direct-to-consumer' is estimated at $391.25 million, reflecting a year-over-year increase of 6.2% [4] - 'Net Sales by Channel- Wholesale' is projected to be $191.80 million, indicating a 7.8% increase from the previous year [4] - 'Net Sales by Category- Other' is expected to reach $8.85 million, showing a 6.7% year-over-year change [4] - 'Net Sales by Category- Drinkware' is forecasted at $367.60 million, suggesting a 2.7% increase year over year [5] - 'Net Sales by Category- Coolers & Equipment' is anticipated to be $206.15 million, indicating a significant year-over-year change of 14.4% [5] Group 3: Geographic Revenue Estimates - 'Geographic Revenues- United States' is projected to be $447.70 million, reflecting a 2.3% increase from the year-ago quarter [5] - 'Geographic Revenues- International' is estimated at $134.22 million, suggesting a substantial year-over-year increase of 23.2% [6] Group 4: Stock Performance and Outlook - Over the past month, Yeti shares have declined by 5.5%, compared to a 1.4% decrease in the Zacks S&P 500 composite [6] - Yeti holds a Zacks Rank 2 (Buy), indicating a likelihood of outperforming the overall market in the upcoming period [6]

Core Viewpoint - Cheesecake Factory (CAKE) is expected to report quarterly earnings of $0.98 per share, a decline of 5.8% year-over-year, with revenues projected at $948.89 million, reflecting a 3% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 1.9% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- North Italia' at $90.20 million, a year-over-year increase of 10.9% [5]. - 'Revenues- The Cheesecake Factory restaurants' are forecasted to reach $669.80 million, suggesting a slight increase of 0.1% year-over-year [5]. - 'Revenues- Other' are expected to be $93.47 million, reflecting a 9.8% increase from the previous year [5]. - The consensus estimate for 'Revenues- Other FRC' stands at $95.67 million, indicating a year-over-year change of 12.4% [6]. Restaurant Metrics - The number of company-owned restaurants for North Italia is projected to reach 48, up from 42 year-over-year [6]. - The number of company-owned restaurants for The Cheesecake Factory is expected to be 218, compared to 215 in the same quarter last year [6]. - Total company-owned restaurants are estimated to reach 372, an increase from 348 year-over-year [7]. - The number of international-licensed restaurants for The Cheesecake Factory is expected to be 36, up from 34 in the same quarter last year [8]. - The estimated number of company-owned restaurants for Other is projected at 49, compared to 43 year-over-year [8]. Operational Insights - Analysts predict 'Total restaurant operating weeks' to reach 2,819, compared to 2,795 in the same quarter last year [9]. - The average prediction for 'Income/(loss) from operations- The Cheesecake Factory restaurants' is $101.10 million, down from $104.39 million in the same quarter last year [9]. Stock Performance - Over the past month, shares of Cheesecake Factory have returned -1.1%, slightly better than the Zacks S&P 500 composite's -1.4% change [10]. - Currently, CAKE holds a Zacks Rank 3 (Hold), suggesting performance may align with the overall market in the near future [10].

Core Insights - Analysts forecast Bausch Health (BHC) will report quarterly earnings of $1.21 per share, reflecting a year-over-year increase of 5.2% and revenues of $2.7 billion, which is a 5.7% increase compared to the previous year [1] Earnings Projections - The consensus EPS estimate for the quarter has been revised upward by 0.6% over the past 30 days, indicating a collective reassessment by analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Total Bausch + Lomb revenues are projected to reach $1.37 billion, indicating a year-over-year change of +7.1% [5] - Revenues from Diversified Products are estimated at $233.84 million, reflecting a +2.6% change from the year-ago quarter [5] - Revenues from Bausch + Lomb- Vision Care are expected to be $778.13 million, showing a +7.6% year-over-year change [5] - Revenues from Bausch + Lomb- Surgical are estimated at $239.46 million, indicating a +3.7% change from the previous year [6] - Total revenues for Bausch Health (excluding B+L) are projected to be $1.33 billion, reflecting a +3.8% year-over-year change [6] - International revenues are expected to reach $280.41 million, showing a +0.5% change from the year-ago quarter [6] - Revenues from Solta Medical are forecasted at $143.46 million, indicating a +4% year-over-year change [7] - Revenues from Salix are estimated at $669.92 million, reflecting a +5.7% change year over year [7] - Revenues from Bausch + Lomb- Pharmaceuticals are projected to be $353.78 million, indicating an +8.5% year-over-year change [7] Stock Performance - Over the past month, Bausch shares have recorded a return of -14.2%, compared to the Zacks S&P 500 composite's -1.4% change, suggesting underperformance relative to the market [7] - BHC holds a Zacks Rank 3 (Hold), indicating that its performance is expected to align with the overall market in the upcoming period [7]

Core Insights - Ardelyx (ARDX) is expected to report quarterly earnings of $0.02 per share, unchanged from the same period last year, with revenues projected at $117.57 million, reflecting a year-over-year increase of 1.2% [1] - The consensus EPS estimate has been revised downward by 50% over the past 30 days, indicating a reassessment by analysts [1] Revenue Projections - Analysts predict 'Revenues- Product sales, net' to reach $114.14 million, representing a 2.8% increase from the prior-year quarter [4] - 'Product sales- IBSRELA' are expected to reach $85.75 million, indicating a significant increase of 59.3% from the prior-year quarter [4] - Conversely, 'Product sales- XPHOZAH' are projected to be $28.39 million, reflecting a decrease of 50.3% from the prior-year quarter [4] Stock Performance - Ardelyx shares have increased by 1.8% over the past month, contrasting with a decline of 1.4% in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - AMN Healthcare Services is expected to report a significant decline in quarterly earnings and revenues, indicating potential challenges ahead for the company [1]. Financial Performance - The anticipated earnings per share (EPS) for AMN Healthcare is $0.22, reflecting a 70.7% decrease compared to the same quarter last year [1]. - Analysts forecast revenues of $723.87 million, which represents a 1.5% decline year over year [1]. Analyst Projections - There have been no revisions in the consensus EPS estimate over the past 30 days, indicating stability in analysts' expectations [1]. - The revenue from 'Physician and leadership solutions' is estimated at $168.50 million, showing a year-over-year decline of 2.7% [4]. - The revenue forecast for 'Nurse and allied solutions' stands at $465.36 million, indicating a year-over-year increase of 2.4% [4]. - The projected revenue for 'Technology and workforce solutions' is $89.97 million, reflecting a significant year-over-year decline of 15.9% [5]. Segment Operating Income - The estimated segment operating income for 'Nurse and allied solutions' is $32.42 million, down from $38.93 million in the previous year [5]. - Analysts predict 'Segment operating income- Technology and workforce solutions' will reach $29.93 million, a decrease from $40.28 million reported in the same quarter last year [6]. - The expected segment operating income for 'Physician and leadership solutions' is $13.80 million, down from $17.03 million year-over-year [6]. Stock Performance - Over the past month, AMN Healthcare shares have declined by 14.6%, contrasting with a 1.4% decline in the Zacks S&P 500 composite [6]. - AMN Healthcare holds a Zacks Rank of 4 (Sell), suggesting it may underperform the overall market in the near future [6].

Core Viewpoint - Howard Hughes Holdings (HHH) is expected to report a significant decline in quarterly earnings and revenues, indicating potential challenges ahead for the company [1]. Financial Performance - Analysts predict HHH will post quarterly earnings of $0.31 per share, reflecting a decline of 90.5% year-over-year [1]. - Revenues are forecasted to be $613.03 million, representing a year-over-year decrease of 37.7% [1]. Earnings Estimates - Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter, indicating stability in analysts' forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock performance [3]. Revenue Breakdown - 'Revenues- Master Planned Community land sales' are estimated to reach $90.89 million, suggesting a year-over-year increase of 34.2% [5]. - 'Revenues- Strategic Developments Segment' is expected to be $388.63 million, indicating a decline of 50.3% from the previous year [5]. - 'Revenues- Operating Assets Segment' is projected to reach $114.23 million, reflecting a slight increase of 1.5% year-over-year [5]. - 'Revenues- Master Planned Communities Segment' is forecasted to be $110.17 million, suggesting a year-over-year increase of 23.4% [6]. Market Performance - HHH shares have experienced a decline of 1.8% over the past month, compared to a 1.7% decline in the Zacks S&P 500 composite [6]. - HHH holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [6].

Core Viewpoint - Analysts forecast Omnicom (OMC) will report quarterly earnings of $2.72 per share, reflecting a year-over-year increase of 12.9%, with anticipated revenues of $4.5 billion, up 4.2% from the previous year [1] Earnings Projections - The consensus EPS estimate has been revised downward by 7% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts expect 'Revenue- Commerce & Branding' to be $176.75 million, a decrease of 9.1% from the prior-year quarter [4] - The estimate for 'Revenue- Execution & Support' is $215.42 million, indicating a 1.7% increase year-over-year [5] - 'Revenue- Healthcare' is projected at $293.75 million, reflecting a decline of 13.4% year-over-year [5] - 'Revenue- Public Relations' is expected to be $454.59 million, showing a slight decrease of 0.4% from the previous year [5] Geographic Revenue Insights - 'Revenue by Geography- Asia Pacific' is estimated to reach $543.15 million, a year-over-year increase of 3.9% [6] - 'Revenue by Geography- Middle East and Africa' is projected at $102.47 million, indicating a decline of 7.4% from the prior-year quarter [6] - 'Revenue by Geography- North America' is expected to be $2.38 billion, reflecting a 3% increase year-over-year [7] - 'Revenue by Geography- Latin America' is forecasted to reach $135.63 million, suggesting a 3.5% increase year-over-year [7] Organic Revenue Growth - Total Organic Revenue Growth is projected at 2.4%, down from 5.2% reported in the same quarter last year [7] - 'Organic Revenue Growth - Experiential' is expected to be -2.3%, compared to 4.9% in the previous year [8] - 'Organic Revenue Growth - Precision Marketing' stands at 3.2%, down from 9.1% year-over-year [8] - 'Organic Revenue Growth - Advertising & Media' is estimated at 6.4%, slightly lower than the 7.1% reported last year [9] Stock Performance - Over the past month, Omnicom shares have declined by 13.5%, contrasting with the Zacks S&P 500 composite's decline of 1.7% [9] - Based on its Zacks Rank 3 (Hold), Omnicom is expected to perform in line with the overall market in the upcoming period [10]

Core Insights - Clean Harbors (CLH) is expected to report quarterly earnings of $1.61 per share, reflecting a year-over-year increase of 3.9% [1] - Anticipated revenues for the quarter are projected at $1.46 billion, which represents a 1.7% increase compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analysts' projections [1] Revenue Estimates - The consensus estimate for 'Revenue- Direct Revenues- Safety-Kleen Sustainability Solutions' is $201.28 million, showing a decrease of 2% from the prior-year quarter [4] - Analysts project 'Revenue- Direct Revenues- Environmental Services' to reach $1.24 billion, indicating a year-over-year increase of 1.4% [4] EBITDA Projections - 'Adjusted EBITDA- Safety-Kleen Sustainability Solutions' is expected to be $31.17 million, up from $24.60 million in the previous year [5] - The consensus for 'Adjusted EBITDA- Environmental Services' is projected at $320.60 million, compared to $310.57 million a year ago [5] Stock Performance - Over the past month, Clean Harbors shares have remained unchanged, while the Zacks S&P 500 composite has decreased by 2% [5] - Clean Harbors holds a Zacks Rank 3 (Hold), suggesting that its performance is likely to align with the overall market in the near term [5]